A subset of patients with non-small cell lung cancer (NSCLC) who discontinued immune checkpoint inhibitor (ICI) therapy due ...

Researchers from Touro University and Lovelace Biomedical are Developing an Innovative Treatment for Lung Cancer ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

Most patients who enroll in the Lung-MAP precision medicine trial in non-small cell lung cancer can now be matched to a targeted investigational treatment based on the results of their prior genomic ...

When Paul Hall was diagnosed with stage 4 lung cancer in October 2021, he said, “I’m not quitting.” ...

A new study published in The Annals of Thoracic Surgery suggests that Medicaid expansion under the Affordable Care Act has ...

In a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased ...

2024 — Researchers examined the impact of obesity in relation to treatment and mortality from data on over 500,000 lung cancer patients. This study suggests that immunotherapy may not be the optimal ...

Patients in expansion states were more likely ... for strategies that improve access to timely and high-quality lung cancer treatment nationwide. Medicaid expansion continues to be a hot button ...

A retired nurse was “sent home to die” after a cancerous tumour was discovered in her lungs at Aberdeen Royal Infirmary.

A breakthrough in cancer treatment may soon change how some of the most aggressive tumors are managed. A small, ...